Former U.S. vice president Dick Cheney, architect of George W Bush’s “War on Terror,” has died at the age of 84.Cheney served ...

The hilarious and food-loving Raphael Gomes dives deeper into the secrets behind ad-perfect food in part three of his ...

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive consumer health goods company ...

The biggest accomplishment of these films and others like them, Johnson contends, is that they made women’s suffering ...

Following achievement of the Return Cap, a royalty-only tail period will commence, which entitles HCRx to a predefined, reduced share of royalties not to exceed $14.9 million per year; the tail period ...

Texas Attorney General Ken Paxton sued two pharmaceutical companies for "deceptively marketing Tylenol to pregnant mothers" ...

Seven candidates are running for four-year terms on the Allentown School Board, and two candidates are running for a two-year ...

The world’s richest gold rush that began in 1891 in what became the Cripple Creek Mining District created endless lines of mined ore carts slogging down the mountain to smelting and milling operations ...

Shares of Johnson & Johnson were rising into record territory in early trading Tuesday, after the medicines and medical-technology giant beat quarterly earnings expectations and raised its outlook, ...

Strengthens focus of Johnson & Johnson (JNJ) as an innovation powerhouse and accelerates the portfolio shift of its MedTech Segment to higher-growth and higher-margin markets Standalone orthopaedics ...

Johnson & Johnson said Tuesday it plans to separate its artificial hip and knee business into a stand-alone company to be called DePuy Synthes—the latest attempt to slim down by the healthcare giant.

The orthopedics business, which generated 10% of 2024 revenue, will be separated from J&J within two years, after its consumer health business was spun off as Kenvue in 2023 Johnson & Johnson's stock ...